Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600195 stock hub

SHA/600195 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600195is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.5B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600195

In the news

Latest news · SHA/600195

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E36.9

P25 17.1P50 24.2P75 37.8

Trailing P/E57.2

P25 23.5P50 41.3P75 83.2

ROE2.2

P25 -0.9P50 4.1P75 8.8

ROIC0.9

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600195 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

CNY

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,996
Employees Change	-303%
Employees Change Percent	-7.05
Enterprise value	CNY 7.5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000000Y03
Last refreshed	2026-05-10
Market cap	CNY 7.5B
Price	CNY 7.37
Price currency	CNY
Rev Per Employee	1,615,251.49x
Sector	Healthcare
Sic	2836
Symbol	sha/600195
Website	https://www.cahic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.75%
EV Earnings	57.12x
EV/EBIT	108.05x
EV/EBITDA	17.8x
EV/FCF	8.16x
EV/Sales	1.16x
FCF yield	12.22%
Forward P/E	36.85x
P/B ratio	1.14x
P/E ratio	57.22x
P/S ratio	1.17x
PE Ratio10 Y	35.2x
PE Ratio3 Y	54.51x
PE Ratio5 Y	43.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.08%
EBITDA Margin	6.45%
FCF margin	14.25%
Gross margin	17.22%
Gross Profit	CNY 1.1B
Gross Profit Growth	12.53%
Gross Profit Growth Q	16.29%
Gross Profit Growth3 Y	-1.95%
Gross Profit Growth5 Y	-3.49%
Net Income	CNY 131.5M
Net Income Growth	125.26%
Net Income Growth Q	-62.23%
Net Income Growth Years	1%
Net Income Growth3 Y	-38.18%
Net Income Growth5 Y	-21.89%
Pretax Margin	3.1%
Profit Margin	2.04%
Profit Per Employee	CNY 32,903
Profitable Years	31
ROA	0.47
Roa5y	1.95
ROCE	0.99
ROE	2.24
Roe5y	5.7
ROIC	0.92
Roic5y	4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.05%
Cagr15y	-1.43%
Cagr1y	7.93%
Cagr20y	9.72%
Cagr3y	-15.43%
Cagr5y	-7.86%
Div CAGR10	-11.95%
Div CAGR3	-49.63%
Div CAGR5	-28.72%
EPS Growth	125.4
EPS Growth Q	-62.2
EPS Growth Years	1
EPS Growth3 Y	-38.2
EPS Growth5 Y	-22
FCF Growth	1,111.22%
OCF Growth	174.48%
OCF Growth10 Y	17.87%
OCF Growth5 Y	27.72%
Revenue Growth	4.94x
Revenue Growth Q	19.86x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	3.45x
Revenue Growth5 Y	4.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.69
Assets	CNY 9.7B
Cash	CNY 1.9B
Current Assets	CNY 4.7B
Current Liabilities	CNY 2.7B
Debt	CNY 975.6M
Debt EBITDA	CNY 2.31
Debt Equity	CNY 0.15
Debt FCF	CNY 1.06
Equity	CNY 6.6B
Interest Coverage	2.27
Liabilities	CNY 3.1B
Long Term Assets	CNY 5B
Long Term Liabilities	CNY 392.8M
Net Cash	CNY 921.1M
Net Cash By Market Cap	CNY 12.24
Net Debt EBITDA	CNY -2.21
Net Debt Equity	CNY -0.14
Net Debt FCF	CNY -1
Tangible Book Value	CNY 5.1B
Tangible Book Value Per Share	CNY 5.04
WACC	5.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.73
Inventory Turnover	5.27
Net Working Capital	CNY 717.3M
Quick ratio	1.16
Working Capital	CNY 2B
Working Capital Turnover	CNY 3.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.04%
Dividend Growth	-80.67%
Dividend Growth Years	0%
Dividend per share	CNY 0.05
Dividend Years	25
Dividend Yield	0.69%
Ex Div Date	2025-07-08
Last Dividend	CNY 0.02
Payout Frequency	Annual
Payout Ratio	35.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	11.04%
1Y total return	7.93%
200-day SMA	7.77
3Y total return	-39.51%
50-day SMA	7.82
50-day SMA vs 200-day SMA	50over200
5Y total return	-33.6%
All Time High	20.77
All Time High Change	-64.52%
All Time High Date	2020-09-07
All Time Low	1.3
All Time Low Change	466.05%
All Time Low Date	2005-07-21
ATR	0.21
Beta	0.37
Beta1y	0.25
Beta2y	0.44
Ch YTD	-6.35
High	7.38
High52	9.03
High52 Date	2026-01-26
High52ch	-18.38%
Low	7.32
Low52	6.76
Low52 Date	2025-05-12
Low52ch	9.02%
Ma50ch	-5.69%
Price vs 200-day SMA	-5.09%
RSI	39.66
RSI Monthly	43.52
RSI Weekly	44.16
Sharpe ratio	0.3x
Sortino ratio	0.68
Total Return	0.73%
Tr YTD	-6.35
Tr15y	-19.49%
Tr1m	-14.7%
Tr1w	-0.27%
Tr3m	-7.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 69.5M
Operating Income Growth	90.34
Operating Income Growth Q	48.92
Operating Income Growth3 Y	-40.04
Operating Income Growth5 Y	-29.12
Operating margin	1.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	499,882,157%
Net Borrowing	141,227,596
Shares Insiders	0.05%
Shares Institutions	5.48%
Shares Out	1,021,148,260
Shares Qo Q	-0.04%
Shares Yo Y	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 920M
Average Volume	24,241,465.75x
Bv Per Share	5.58
CAPEX	CNY -240.5M
Ch10y	-1.55
Ch15y	-33.5
Ch1m	-14.7
Ch1w	-0.27
Ch1y	7.59
Ch20y	402
Ch3m	-7.06
Ch3y	-41.6
Ch5y	-37.33
Ch6m	-4.9
Change	0.41%
Change From Open	0.41
Close	7.34
Days Gap	0
Depreciation Amortization	347,095,362
Dollar Volume	53,516,518
Earnings Date	2026-04-24
EBIT	CNY 69.5M
EBITDA	CNY 416.6M
EPS	CNY 0.13
F Score	7
FCF	CNY 920M
FCF EV Yield	12.25x
FCF Per Share	CNY 0.9
Financing CF	122,563,078
Fiscal Year End	December
Founded	1,998
Goodwill	42,303,929
Graham Number	4.02078
Graham Upside	-45.44
Income Tax	CNY 52.8M
Investing CF	-422,902,380
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2020-07-08
Last Split Type	Forward
Lynch Fair Value	CNY 0.64
Lynch Upside	-91.26
Ma150	7.81
Ma150ch	-5.63%
Ma20	7.79
Ma20ch	-5.38%
Net CF	855,899,912
Open	7.34
P FCF Ratio	8.18
P OCF Ratio	6.49
Payment Date	2025-07-08
Position In Range	83.33
Ppne	3,108,314,195
Price Date	2026-05-08
Price EBITDA	CNY 18.06
Ptbv Ratio	1.46
Relative Volume	0.3x
Revenue	6,454,544,958x
Tax By Revenue	0.82x
Tax Rate	26.33%
Tr20y	539.52%
Tr6m	-4.9%
Volume	7,261,400

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600195 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.05 annual per share

Payout ratio

+35.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-28.7%

0 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2025-07-08

Performance

SHA/600195 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600195?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.5%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

SHA/600195 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.7

Neutral momentum band

Price vs 200-day MA

-5.1%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600195

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600195 stock rating?

sha/600195 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600195 analysis?

The full report lives at /stocks/sha/600195/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600195?

The latest report frames sha/600195 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600195 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.